Acrivon Therapeutics (ACRV) Social Media Sentiment and Mentions → My #1 investment for 2024 (From True Market Insiders) (Ad) Free ACRV Stock Alerts $8.89 +0.33 (+3.86%) (As of 05/17/2024 ET) Add Compare Share Share Social MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Media Mentions Over Time2 Last Week 15 Current Week +650.0%View Trending Media Stocks MarketBeat New Follows Over TimeView Trending Stocks on MarketBeat MarketBeat Searches Over Time Recieve Acrivon Therapeutics News and Ratings via Email Sign-up to receive the latest news and ratings for ACRV and its competitors with MarketBeat's FREE daily newsletter. Email Address ACRV Social Media MentionsAd True Market InsidersMy #1 investment for 2024It’s something you use every single day and don’t even know it.Click here to see my #1 investment for 2024. Related Companies and Tools Related Companies: Organigram Social Sentiment Inventiva Social Sentiment Telomir Pharmaceuticals Social Sentiment Atossa Therapeutics Social Sentiment Lifecore Biomedical Social Sentiment Incannex Healthcare Social Sentiment Zevra Therapeutics Social Sentiment Galectin Therapeutics Social Sentiment Greenwich LifeSciences Social Sentiment Trevi Therapeutics Social Sentiment Social Media Tools: Trending Media MentionsHigh Media Sentiment StocksTrending WallStreetBets Stocks This page (NASDAQ:ACRV) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlaceThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaWhat’s Really Next for America…Porter & CompanyExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersProtect Your Bank Account Before It’s Too LateWeiss RatingsPOTUS in ‘25 Not Biden/Trump, ButThe Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acrivon Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
